# A Retrospective Observational Study of Epidemiology and Outcomes in Transthyretin Amyloid Cardiomyopathy in Germany

> **NCT07494656** · — · RECRUITING · sponsor: **Pfizer** · enrollment: 1 (estimated)

## Conditions studied

- ATTR-CM (Transthyretin Amyloid Cardiomyopathy)

## Interventions

- **OTHER:** tafamidis 61mg (based on prescription data)

## Key facts

- **NCT ID:** NCT07494656
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-02
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-04-30
- **Target enrollment:** 1 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07494656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07494656, "A Retrospective Observational Study of Epidemiology and Outcomes in Transthyretin Amyloid Cardiomyopathy in Germany". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07494656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*